The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by James Vardiman and Harvey M. Golomb.
Connection Strength

1.245
  1. Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B. Leuk Lymphoma. 1991; 4(2):99-102.
    View in: PubMed
    Score: 0.098
  2. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am J Clin Pathol. 1988 Sep; 90(3):250-6.
    View in: PubMed
    Score: 0.084
  3. Sequential treatment of hairy cell leukemia: a new role for interferon. Important Adv Oncol. 1986; 311-21.
    View in: PubMed
    Score: 0.069
  4. Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist? Blood. 1985 Dec; 66(6):1358-61.
    View in: PubMed
    Score: 0.069
  5. Autopsy findings in hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4):370-80.
    View in: PubMed
    Score: 0.064
  6. Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4 Suppl 2):502-8.
    View in: PubMed
    Score: 0.064
  7. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983 Feb; 61(2):349-52.
    View in: PubMed
    Score: 0.057
  8. Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia. Am J Hematol. 1982 Jun; 12(4):397-401.
    View in: PubMed
    Score: 0.054
  9. Hairy cell leukemia: an autopsy study. Cancer. 1979 Apr; 43(4):1339-49.
    View in: PubMed
    Score: 0.044
  10. Hairy cell leukemia: diagnosis and management. CA Cancer J Clin. 1978 Sep-Oct; 28(5):265-77.
    View in: PubMed
    Score: 0.042
  11. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8.
    View in: PubMed
    Score: 0.031
  12. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol. 1993 Mar; 83(3):519-20.
    View in: PubMed
    Score: 0.029
  13. CD5+, CD11c+, CD20+ hairy cell leukemia. Blood. 1991 Apr 01; 77(7):1617-9.
    View in: PubMed
    Score: 0.025
  14. Familial Lymphoproliferative Disorders with Chromosomal Fragile Site Analysis. Leuk Lymphoma. 1991; 5(5-6):311-6.
    View in: PubMed
    Score: 0.025
  15. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5.
    View in: PubMed
    Score: 0.024
  16. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
    View in: PubMed
    Score: 0.022
  17. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
    View in: PubMed
    Score: 0.021
  18. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83.
    View in: PubMed
    Score: 0.020
  19. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3.
    View in: PubMed
    Score: 0.019
  20. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol. 1987 Mar; 18(3):211-25.
    View in: PubMed
    Score: 0.019
  21. The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
    View in: PubMed
    Score: 0.018
  22. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
    View in: PubMed
    Score: 0.018
  23. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
    View in: PubMed
    Score: 0.018
  24. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
    View in: PubMed
    Score: 0.017
  25. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984 Jun; 81(6):733-41.
    View in: PubMed
    Score: 0.016
  26. Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. N Engl J Med. 1984 Jan 26; 310(4):263-4.
    View in: PubMed
    Score: 0.015
  27. Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol. 1983 May; 79(5):525-30.
    View in: PubMed
    Score: 0.014
  28. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug; 60(2):404-11.
    View in: PubMed
    Score: 0.014
  29. Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
    View in: PubMed
    Score: 0.013
  30. Ultrastructural characterization of de novo and secondary leukemias. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 39(3):239-57.
    View in: PubMed
    Score: 0.013
  31. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67.
    View in: PubMed
    Score: 0.013
  32. Prognostic significance of immunological tests in lung cancer. Clin Exp Immunol. 1981 Feb; 43(2):362-9.
    View in: PubMed
    Score: 0.012
  33. Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia. Cancer. 1980 Jul 01; 46(1):50-5.
    View in: PubMed
    Score: 0.012
  34. "Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity. Blood. 1980 Feb; 55(2):253-9.
    View in: PubMed
    Score: 0.012
  35. Cytochemistry of hairy cells. Cancer. 1980 Jan 01; 45(1):72-7.
    View in: PubMed
    Score: 0.011
  36. Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 1979 Sep; 39(9):3619-27.
    View in: PubMed
    Score: 0.011
  37. Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: cytochemical, functional, and clinical correlations. Br J Haematol. 1979 Sep; 43(1):156-7.
    View in: PubMed
    Score: 0.011
  38. Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med. 1978 Sep 21; 299(12):613-9.
    View in: PubMed
    Score: 0.010
  39. Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
    View in: PubMed
    Score: 0.010
  40. Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb; 38(2):161-70.
    View in: PubMed
    Score: 0.010
  41. Acute leukemia after treatment of lymphoma. N Engl J Med. 1977 Nov 03; 297(18):1013.
    View in: PubMed
    Score: 0.010
  42. Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Arch Intern Med. 1976 Jul; 136(7):825-8.
    View in: PubMed
    Score: 0.009
  43. Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul; 48(1):9-21.
    View in: PubMed
    Score: 0.009
  44. Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6.
    View in: PubMed
    Score: 0.007
  45. Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression. Leukemia. 1990 Dec; 4(12):863-5.
    View in: PubMed
    Score: 0.006
  46. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
    View in: PubMed
    Score: 0.005
  47. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
    View in: PubMed
    Score: 0.005
  48. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
    View in: PubMed
    Score: 0.004
  49. Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
    View in: PubMed
    Score: 0.004
  50. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May; 76(5):827-41.
    View in: PubMed
    Score: 0.004
  51. The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36.
    View in: PubMed
    Score: 0.004
  52. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983 Sep 15; 309(11):630-6.
    View in: PubMed
    Score: 0.004
  53. Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet Cytogenet. 1983 Feb; 8(2):107-15.
    View in: PubMed
    Score: 0.004
  54. Histiocytic lymphoma: response to chemotherapy. Ann Intern Med. 1982 Oct; 97(4):617-8.
    View in: PubMed
    Score: 0.003
  55. Hairy cell leukemia in father and son. Cancer. 1981 Oct 15; 48(8):1825-9.
    View in: PubMed
    Score: 0.003
  56. Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood. 1980 Apr; 55(4):636-44.
    View in: PubMed
    Score: 0.003
  57. Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia. Cancer. 1979 Feb; 43(2):411-6.
    View in: PubMed
    Score: 0.003
  58. Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. Blood. 1978 Aug; 52(2):272-80.
    View in: PubMed
    Score: 0.003
  59. Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer. 1977 Dec 15; 20(6):869-72.
    View in: PubMed
    Score: 0.002
  60. Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood. 1977 Jun; 49(6):883-93.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.